Applications are invited from the eligible candidates for recruitment to the following No.of vacant posts in the UPHCs of Kurnool District on contract basis initially for a period of one year, through WALK-IN-INTERVIEW, under the following Roster Points as noted below against each post.

Post : Pharmacist Gr.II

Indo-German Science & Technology Centre (IGSTC) was established by the Department of Science & Technology (DST), Government of India and the Federal Ministry of Education and Research (BMBF), Government of Germany to facilitate and promote Indo-German collaboration in Science and Technology (S&T) through substantive interactions between researchers of both India & Germany.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Walk in interview for Formulations Manufacturing plant.

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2005 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Formulation Unit dealing in regulated markets having approval like MHRA. T6A & 6LC etc.

Gracure Pharmaceutical Ltd. is a Delhi based pharmaceutical company, established in 1992 by Mr. A.S Bhargava with the vision of making world class affordable medicines.

Post : Research Associate / Senior Research Associate

Janssen India, the pharmaceutical division of Johnson & Johnson India, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neuroscience and analgesia, dermatology, infectious diseases and metabolic diseases. Driven by a strong dedication to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world.

NHM/NUHM/GUHP is being implemented in the district under District Health Society, Jamnagar. Which mainly includes Maternal Welfare, Family Welfare and Adolescent Health etc. For the implementation of the programme, the following posts are to be filled in the various societies under the District Health Society and a waiting list is to be created for the vacant / vacant posts in the future.

Post : Pharmacist

IISERs were created through a proclamation of Ministry of Education, Government of India, to promote quality education and research in science and related areas. The first two IISERs (Pune and Kolkata) were established in 2006. This was followed by an Institute at Mohali (2007), Bhopal & Trivandrum (2008), Tirupati (2015), and Berhampur (2016). IISERs were incorporated as Institutions of National Importance under the umbrella of the NIT (Amendment) Act, 2012 (NIT Act 2007). The Act was further amended in 2014, entitled the NITSER ACT 2014.

Candidates are appointed for the following posts on contract basis in various health institutes of Wayanad district Eligible candidates with certificates proving eligibility (SSLC & above), experience, other related certificate, and ID card with photo.) 2023 - 14 m Health Kerala office will not accept post.  Application through or in person should be submitted before 5 PM.

Post : Pharmacist

The mandate of the Institute is to address the reproductive health issues of national and global relevance. The institute was established with an objective to develop novel and efficacious modalities for fertility regulation through research and thereby assist the government in its mission to stem the population boom. In the past four decades, however, the institute has grown beyond the mandate with which it was entrusted at the time of its genesis.

A manufacturing facility having approval from more than 25 different regulatory authorities including USFDA, MHRA, ANYISA etc. The facility is equipped to manufacture multiple dosage forms and has state of the art manufacturing setup and Quality Control Lab.

Cadila Pharmaceuticals Ltd. (CPL) Is one of India’s most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its Corporate Office at Bhat, Ahmedabad and State-of-art manufacturing facilities at Dholka, Ankleshwar, Kadi and Jammu accredited with USFDA, MHRA, TGA, MCA, MCC & WHO certifications.

Walk In Drive at Udaipur

Lincoln Pharmaceuticals Ltd., Ahmedabad based 40 years old, public limited having presence in 75+ countries, 1700+ registered products, own Manufacturing and R&D center and among india’s top 70 pharma company.

Glenmark Pharmaceutical Ltd, Baddi (H.P.) A manufacturing facility having approval from more than 25 different regulator authorities including USFDA, MHRA, ANVISA etc. The facility is equipped to manufacture multiple dosage forms and has state of the art manufacturing setup and Quality Control Lab.

Looking for professionals having experience in formulations of MDI/lnhalers, External preparation, sterile and Liquids.

Surgical removal of the tonsils and adenoids in children with snoring and mild breathing problems during sleep appears to improve their sleep, quality of life, and blood pressure a year after surgery, a clinical trial supported by the National Institutes of Health has found. The study, funded by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, is believed to be the first large, randomized trial to address the effects of adenotonsillectomy on children with mild sleep-disordered breathing (SDB).

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

To speed up their growth, leukemia cells typically activate the recycling of cellular structures – enabling them to dispose of defective components and better supply themselves with building materials. Researchers at Goethe University Frankfurt have now shown that leukemia cells with a very common mutation activate specific genes that are important for this recycling process. Their findings, published in the journal Cell Reports, open up new therapeutic options for the future.

Self-folding polymers containing gadolinium forming nanosized complexes could be the key to enhanced magnetic resonance imaging and next-generation drug delivery, as demonstrated by scientists at Tokyo Tech. Thanks to their small size, low toxicity, and good tumor accumulation and penetration, these complexes represent a leap forward in contrast agents for cancer diagnosis, as well as neutron capture radiotherapy.

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Fabhalta® (iptacopan) as the first oral monotherapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH). Fabhalta is a Factor B inhibitor that acts proximally in the alternative complement pathway of the immune system, providing comprehensive control of red blood cell (RBC) destruction within and outside the blood vessels (intra- and extravascular hemolysis [IVH and EVH]).